These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2956845)
21. [Restenosis after coronary angioplasty: its pathogenesis and prevention]. Marzocchi A; Marrozzini C; Piovaccari G; Fattori R; Castriota F; D'Anniballe G; Branzi A; Magnani B Cardiologia; 1991 Dec; 36(12 Suppl 1):309-20. PubMed ID: 1841786 [TBL] [Abstract][Full Text] [Related]
22. [Mechanisms of re-stenosis after angioplasty]. Bauriedel G; Kandolf R; Welsch U; Höfling B Z Kardiol; 1994; 83 Suppl 4():31-41. PubMed ID: 7856278 [TBL] [Abstract][Full Text] [Related]
23. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Godfried SL; Deckelbaum LI Am Heart J; 1995 Jan; 129(1):203-10. PubMed ID: 7817919 [No Abstract] [Full Text] [Related]
24. Role of endothelial cells in restenosis after coronary angioplasty. Meurice T; Vallet B; Bauters C; Dupuis B; Lablanche JM; Bertrand ME Fundam Clin Pharmacol; 1996; 10(3):234-42. PubMed ID: 8836697 [TBL] [Abstract][Full Text] [Related]
25. Percutaneous transluminal coronary angioplasty restenosis: potential prevention with laser balloon angioplasty. Spears JR Am J Cardiol; 1987 Jul; 60(3):61B-64B. PubMed ID: 2956846 [TBL] [Abstract][Full Text] [Related]
26. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915 [TBL] [Abstract][Full Text] [Related]
27. Is the Watanabe heritable hyperlipidemic rabbit a suitable experimental model for percutaneous transluminal coronary angioplasty in humans? A light microscopic, immunohistochemical and ultrastructural study. Wanibuchi H; Dingemans KP; Becker AE; Ueda M; Naruko T; Tanizawa S; Nakamura K J Am Coll Cardiol; 1993 May; 21(6):1490-6. PubMed ID: 8473661 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis. Benchimol D; Benchimol H; Bonnet J; Dartigues JF; Couffinhal T; Bricaud H Am J Cardiol; 1990 Apr; 65(15):980-5. PubMed ID: 2327359 [TBL] [Abstract][Full Text] [Related]
29. First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplasty. Schmid KM; Preisack M; Voelker W; Sujatta M; Karsch KR Semin Thromb Hemost; 1993; 19 Suppl 1():155-9. PubMed ID: 8395719 [TBL] [Abstract][Full Text] [Related]
30. Comparison of dissection rates and angiographic results following directional coronary atherectomy and coronary angioplasty. Rowe MH; Hinohara T; White NW; Robertson GC; Selmon MR; Simpson JB Am J Cardiol; 1990 Jul; 66(1):49-53. PubMed ID: 2360533 [TBL] [Abstract][Full Text] [Related]
31. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. Roubin GS; King SB; Douglas JS Am J Cardiol; 1987 Jul; 60(3):39B-43B. PubMed ID: 2956840 [TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of restenosis. A correlation of clinical observations with cellular responses. Haudenschild CC Z Kardiol; 1990; 79 Suppl 3():17-22. PubMed ID: 2099039 [TBL] [Abstract][Full Text] [Related]
33. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609 [TBL] [Abstract][Full Text] [Related]
34. Risk factors, time course and treatment effect for restenosis after successful percutaneous transluminal coronary angioplasty of chronic total occlusion. Ellis SG; Shaw RE; Gershony G; Thomas R; Roubin GS; Douglas JS; Topol EJ; Startzer SH; Myler RK; King SB Am J Cardiol; 1989 Apr; 63(13):897-901. PubMed ID: 2522727 [TBL] [Abstract][Full Text] [Related]
35. [Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects]. Hombach V; Waltenberger J; Voisard R; Höher M Z Kardiol; 1995 Jan; 84(1):5-21. PubMed ID: 7863714 [TBL] [Abstract][Full Text] [Related]